In Vitro Pre-Clinical Evaluation of a Gonococcal Trivalent Candidate Vaccine Identified by Transcriptomics
Shea K. Roe, Brian Felter, Bo Zheng, Sanjay Ram, Lee M. Wetzler, Eric Garges, Tianmou Zhu, Caroline A. Genco, Paola Massari · 2023
Read In Vitro Pre-Clinical Evaluation of a Gonococcal Trivalent Candidate Vaccine Identified by Transcriptomics by Shea K. Roe, Brian Felter, Bo Zheng, Sanjay Ram, Lee M. Wetzler, Eric Garges, Tianmou Zhu, Caroline A. Genco, Paola Massari (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10747275.txt.
Description
Gonorrhea is spreading and shrugging off drug after drug, so a vaccine matters more each year, yet no strong candidate has reached the clinic. Shea Roe and co-authors test a three-part candidate in a 2023 lab study. The parts were picked from genes the germ switches on while it infects people, a hunt based on the germ's own activity log.
Blood from infected people did react to the chosen parts, a good early sign. In mice, the mix raised germ-killing antibodies, and the choice of booster in the shot changed the result. A booster that pushed one arm of the immune system gave stronger killing power. The team backs the mix as a promising path, while noting that mouse and dish tests are only the first gate.
Catalog record
| CREATOR | Shea K. Roe, Brian Felter, Bo Zheng, Sanjay Ram, Lee M. Wetzler, Eric Garges, Tianmou Zhu, Caroline A. Genco, Paola Massari |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |